RxDoctor Payments Data

Adam Bledsoe, MD

Gastroenterology · Rochester, MNNPI 1073929733

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Olympus America Inc.. That places this record below the midpoint for gastroenterology clinicians in MN, where the typical reported total is $127.

$55in general payments, 2019–2025

Across 1 payment — averaging $55.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$55
$188,655in research payments, 2019–2025

Across 23 payments — averaging $8202.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Chugai Pharmaceutical Co., Ltd.$135K
  • Sanofi US Services Inc.$54K

What the payments were for

  • Food & beverage$55100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Olympus America Inc.1$55

How this compares

$55 in reported general payments places this provider in the 40th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$55,427
Medicare patients
267
Services billed
426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole11$85

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →